Sara D. Avila

Sara is a member of the firm’s class action and complex litigation department. Sara is dedicated to representing plaintiffs in complex litigation and consumer class actions. Her practice is focused on consumer fraud, with an emphasis in false advertising and consumer deception.  She also has experience representing plaintiffs in cases stemming from antitrust violations, landlord-tenant disputes, employment violations and insurance bad faith.

Sara has been appointed class counsel in several state and federal class actions, including: Barba v. Shire U.S., Inc. (S.D. Fla. No. 1:13-cv-21158) (2016) (representing purchasers in action alleging pharmaceutical manufacturer delayed entry of generic Adderall XR®); Garcia, et al., v. Kashi Co., S.D. Fla. No. 12-21678 (2016) (representing purchasers in action alleging ‘all natural’ claims on food items were misleading); Toney v. Just Fabulous (Los Angeles Superior Court Case No. BC533943) (2015) (representing “VIP” members of JustFab regarding overcharges for restocking fees and monthly auto-billing); Paul v. Wine.com (San Francisco Superior Court Case No. CGC-13-534734) (2015) (alleging violations of California’s automatic purchase renewal statute and misleading “free shipping” representations); Arreguin v. Telebrands (San Bernardino Superior Case No. CVRS 13307798) (2015) (representing purchasers in action alleging the “Pockethose” was defective);  McCrary v. The Elations Co., LLC  (C.D. Cal., No. EDCV 13-00242 JGB) (2014) (representing California purchasers of Elations “joint health supplement beverage” alleging false claims of “clinical-proof” on product labeling); Saenz v.  SEIU United Healthcare Workers-West (Alameda Super.  Ct.  No. RG09478973) (2013) (representing individuals against labor union for data security breach); Pabst v. Genesco, Inc. (N.D. Cal. No. 3:11-cv-01592-SI) (2012) (representing California consumers regarding an alleged privacy violation); Weeks, et al. v. Kellogg, et al. (C.D. Cal., No. CV-09-08102 (MMM) (2010) (representing purchasers in action alleging food product’s “immunity” claims were false and misleading).

Sara has helped successfully secure recoveries for many of her clients. Most recently, she was part of a team who obtained preliminary approval of a class action settlement requiring a pharmaceutical manufacturer to pay $15 million for its involvement in allegedly blocking generic drug competition.   She was featured as a “Southern California Rising Star” in Super Lawyers® in 2015 and 2016.